|
Qty |
  |
Title |
| | 1953-2003: A Historical Perspective |
| | Are the Benefits of Newer Drugs... (Lichtenberg) |
| | Assessing the Impact of Rx Innovation (Meyer) |
| | Audio Medicaid 101 |
| | Availability New Drugs and Americans' Abillity to Work |
| | CD-ROM - Medicaid 101 |
| | CD-ROM Human Genome Variation & Racial Disparitie |
| | CD-ROM Racial & Ethnic Differences in Response |
| | CD-ROM Shifiting Paradigms on Race & Medicine |
| | CD-ROM: Value of Rx Innovation |
| | CD-ROM-Prescription Medicines: Returning Value |
| | Clinical & Economic Advantages of Modern Dosage Form |
| | Closer Look at Allergies, A |
| | Closer Look at Arthritis, A |
| | Closer Look at Asthma, A |
| | Closer Look at Depression, A |
| | Closer Look at Diabetes, A |
| | Closer Look at High Blood Pressure, A |
| | Closer Look at High Cholesterol, A |
| | Component Management Fails to Save Health Care System Costs: |
| | Consumers'Reports on Health Effects of DTC Drug Adve |
| | Coordinated Pharmaceutical Therapy in Chronic Care: Five Inn |
| | Costs and Benefits of Pharmaceuticals: Value Equation |
| | Cultural and Genetic Diversity in America |
| | Current Evidence-Based Medicine Landscape |
| | Demystifying Comparative Effectiveness Research |
| | Disease Management for Asthma |
| | Disease Management for COPD |
| | Disease Management for Depression |
| | Disease Management for Diabetes |
| | Disease Management for Heart Failure |
| | Disease Management for Schizophrenia |
| | Drug Delivery Systems Improve Pharm Profile |
| | Effectiveness of Interventions to Improve Patient Compliance |
| | Employer Medication Compliance Initiatives |
| | Employer's Guide to Patient-Directed Healthcare B, An |
| | Employer's Guide to Pharmaceutical Benefits, An |
| | Ethnic Disparities in the Burden & Treatment of Asthma |
| | Ex. Summ - Demystifying Comparative Effect. Research |
| | Exec. Summary - Coordinated Rx Therapy |
| | Exec. Summary - Improving and Measuring Osteo |
| | Exec. Summary - Value of Investment in Health Care |
| | Explaining Drug Trends: Does Perception Match Reality? |
| | Fact Sheet: Medicaid Outcomes Program Reduces Asthma Emergen |
| | Fact Sheet: West Virginia Health Initiative Project |
| | Formulary Limitations and the Elderly: Results from the Mana |
| | Framing the Debate |
| | Full Rpt-Value of Investment in Health Care |
| | Future Costs, Risks and Rewards of Drug Development |
| | Genes, Culture, and Medicines: Bridging Gaps |
| | Growth in Use of Lipid-lowering Therapies |
| | Health & Productivity Cost Burden of 'Top 10' |
| | Health Affairs (Book), Sept/Oct 2001 |
| | Health Affairs Primer, Value of Rx Innovation |
| | Health Care & Productivity |
| | Health Plan Capabilities to Support Value Based Benefit |
| | Health, Absence, Disability & Presenteeism |
| | Impact of Disease Management on Outcomes and Cost of Car, The |
| | Impact on States Medicare Drug Benefit - State Admins |
| | Impact on States of Medicare Drug Benefit - Legislators |
| | Improving and Measuring Osteoporosis Management |
| | Improving the Quality of Pain Management |
| | Integrating Pharmaceutical Care: A Vision and Framework |
| | Intended and Unintended Consequences of HMO Cost Containment |
| | Is Technological Change in Medicine... (Cutler et al.) |
| | Link Between Gross Profitability... (Scherer), The |
| | Measuring the costs and benefits of pharmaceutical ex |
| | Medicaid Disease Management Programs |
| | NICE Executive Summary |
| | NICE: How Does It Work and Implications for US? |
| | Noncompliance with Medications: An Economic Tragedy with Imp |
| | NPC Capabilities Brochure |
| | Pain Exec. Summary: An Overview of Two Monographs |
| | Pain: Assessment, Management and Treatment |
| | Patient adherence to HIV medication regimens: a revie |
| | PDL-State Medicaid Program Issues |
| | Perspectives on the Rx Industry (Reinhart) |
| | Pharmaceuticals & Worker Productivity Loss |
| | Pharmaceuticals and Productivity (Tau) |
| | Pharmacy Benefit Trifold |
| | Price of Progress:... (Kleinke), The |
| | Racial and Ethnic Differences in Response to Medicines |
| | Resources for Medicare Beneficiaries: Navigating |
| | State Medicaid Resource Kit |
| | Supplement JNCCN - Cancer |
| | Too Many Drugs? Clinical & Economic Value |
| | Too Many Drugs? Exec. Summary Reprint |
| | Toward Individualized Pharm. Care of East Asians |
| | Urinary Incontinence: Economic Burden & New Choices |
| | Value in Health: Assessing CER & Comparative Value |
| | Value of Combination Drugs: Innovation in Pharmacoth |
| | Value of Incremental Innovation for Older American, The |
| | Value-Based Insurance Design Landscape Digest |
| | Virginia Health Outcomes Partnership: A Demonstration Pr, The |
| | Virginia Health Outcomes Partnership: A Unique Approach, The |
| | What to Do if Your Medicine Isn't Covered |
| | Why the Elderly Need Individualized Pharmaceutical Care, by |
| | Your Pharmacy Benefit-Make It Work for You |